Program will be added once finalised.
Program
This edition will feature the following themes:
- Alternative to current antibiotics & antivirals
- Immunotherapies & new biotherapeutics
- One Health Approach to Tackling Infectious Diseases
- Innovations in human vaccines
- Global Challenges in Animal Infectious Diseases
- Advances in Diagnostics, Prognostics and Biomarker Discovery
This edition will feature the following themes:
- Innovative Alternatives to Antibiotics and Antivirals
- Emerging Immunotherapies Approaches
- One Health Approaches to Emerging Infectious Challenges
- Next-Generation Human Vaccines
- Emerging Solutions for Animal Health
- Advances in Diagnostics, Prognostics and Biomarker Discovery
2026 Speaker already confirmed
Erin Duffy
Chief of Research & Development
CARB-X, USA
Lisa Osbelt-Block
Researcher
Helmholtz Center for Infection Research, Germany
Vincent Marechal
Professor
Sorbonne University
Director
National platform OBEPINE+
Mélanie Hamon
Head of the Chromatin and Infection group
Institut Pasteur, France
Helen Bright
CSO
Centauri Therapeutics, United Kingdom
Nicolas Burdin
Global Head of R&D
CloverBiopharmaceuticals, France
Victoria Savage
CSO
Infex Therapeutics Ltd, United Kingdom
Stuart Hannah
CEO
Microplate Dx, Scotland
